Get the Stockscreener App
4.05
19.88%
0.63
Mangoceuticals Inc stock is traded at $4.05, with a volume of 671.83K.
It is up +19.88% in the last 24 hours and up +50.74% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$3.42
Open:
$3.64
24h Volume:
671.83K
Relative Volume:
9.18
Market Cap:
$8.50M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.7093
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
+35.54%
1M Performance:
+50.74%
6M Performance:
-28.07%
1Y Performance:
-32.01%
1-Day Range:
$3.60
$4.40
1-Week Range:
$2.855
$4.40
52-Week Range:
$2.07
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
4.08 | 8.50M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
236.61 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.10 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
79.41 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
67.09 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.99 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals advances in H1N1 and H5N1 studies - Investing.com
Mangoceuticals executes exclusive distribution agreement with Propre - MSN
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Major Skincare Breakthrough: Clinical Tests Show New Plant-Based Treatment Outperforms Leading Solutions - StockTitan
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada
Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World
Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading - Stocks Telegraph
Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent - MarketWatch
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals - TipRanks
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewswire
Mangoceuticals inks new service agreement, issues equity By Investing.com - Investing.com Nigeria
Mangoceuticals inks new service agreement, issues equity - Investing.com India
Mangoceuticals probes unusual stock activity post-split - Investing.com
Mangoceuticals initiates investigation into potential stock manipulation - TipRanks
Mangoceuticals probes unusual stock activity post-split By Investing.com - Investing.com UK
Mangoceuticals, Inc. Initiates Investigation into Potential - GlobeNewswire
MangoRx Launches Investigation Into Suspicious Trading Activity After Stock Split - StockTitan
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
Financial Survey: Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) & Its Competitors Financial Analysis - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
8.73%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):